C519-2072 Screening compound: 1-ethyl-4-oxo-N-[3-(propan-2-yloxy)propyl]-6-(1,2,3,4-tetrahydroisoquinoline-2-sulfonyl)-1,4-dihydroquinoline-3-carboxamide

C519-2072 Screening compound: 1-ethyl-4-oxo-N-[3-(propan-2-yloxy)propyl]-6-(1,2,3,4-tetrahydroisoquinoline-2-sulfonyl)-1,4-dihydroquinoline-3-carboxamide
C519-2072 Screening compound: 1-ethyl-4-oxo-N-[3-(propan-2-yloxy)propyl]-6-(1,2,3,4-tetrahydroisoquinoline-2-sulfonyl)-1,4-dihydroquinoline-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C519-2072
1-ethyl-4-oxo-N-[3-(propan-2-yloxy)propyl]-6-(1,2,3,4-tetrahydroisoquinoline-2-sulfonyl)-1,4-dihydroquinoline-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C519-2072

Molecular Formula

C27H33N3O5S (C27 H33 N3 O5 S)

Compound Name

1-ethyl-4-oxo-N-[3-(propan-2-yloxy)propyl]-6-(1,2,3,4-tetrahydroisoquinoline-2-sulfonyl)-1,4-dihydroquinoline-3-carboxamide

IUPAC name

1-ethyl-4-oxo-N-[3-(propan-2-yloxy)propyl]-6-(1234-tetrahydroisoquinoline-2-sulfonyl)-14-dihydroquinoline-3-carboxamide

SMILES

CCN(C=C1C(NCCCOC(C)C)=O)c(ccc(S(N(CC2)Cc3c2cccc3)(=O)=O)c2)c2C1=O

InChI

InChI=1S/C27H33N3O5S/c1-4-29-18-24(27(32)28-13-7-15-35-19(2)3)26(31)23-16-22(10-11-25(23)29)36(33,34)30-14-12-20-8-5-6-9-21(20)17-30/h5-6,8-11,16,18-19H,4,7,12-15,17H2,1-3H3,(H,28,32)

InChI Key

RMDLZOPKHQAGRZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14765009

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

511.64

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.092

Distribution Coefficient, logD

3.092

Water Solubility, LogSw

-3.68

Polar Surface Area

78.659

Acid Dissociation Constant (pKa)

13.39

Base Dissociation Constant (pKb)

2.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.70

C519-2072 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Regenerative Medicine Focused Library (23016 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C519-2072 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C519-2072?
Check Price and Availability of C519-2072, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C519-2072 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C519-2072
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C519-2072
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C519-2072 available by request